Patent ID: 8227414

Claim:
Peptide having general formula (I) Xaa 1 -Ψ-Gly 2 -Gly 3 -Xbb 4 -Thr 5 -Gly 6 -Aib 7 -Arg 8 -Lys 9 - (I) Ser 10 -Ala 11 -Arg 12 -Lys 13 -Arg 14 -Lys 15 -R wherein: when Xaa 1 is Phe; ψ represents the bond between the first two amino acid residues and is selected from the group consisting of CO—NH and CH 2 —NH and CH 2 —O; and Xbb 4 is pFPhe where “p” indicates the para-position in the phenyl ring of Phe; or when Xaa 1 is N-benzyl-glycine (Nphe), ψ represents the bond between the first two amino acid residues and is CO—NH, and Xbb 4 is Phe; R represents the dipeptide Asn-Gln-NH 2 or an amino (—NH 2 ) terminal group; and its pharmaceutically acceptable salts.